Mesalamine Delayed Release Tablets and Tocilizumab
Determining the interaction of Mesalamine Delayed Release Tablets and Tocilizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: tocilizumab
Brand name: Actemra, Actemra ACTPen
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Delayed Release Tablets-Tocilizumab (Intravenous)
- Mesalamine Delayed Release Tablets-Tocilizumab Auto-Injectors
- Mesalamine Delayed Release Tablets-Tocilizumab Prefilled Syringes
- Mesalamine Delayed Release Tablets-Todays Health Nasal Relief Extra Moisturizing
- Mesalamine Delayed Release Tablets-Tofacitinib
- Mesalamine Delayed Release Tablets-Tofacitinib Citrate
- Tocilizumab-Mesalamine Long-Acting Capsules (Apriso)
- Tocilizumab-Mesalamine Long-Acting Capsules (Delzicol)
- Tocilizumab-Mesalamine Long-Acting Capsules (Pentasa)
- Tocilizumab-Mesalamine rectal
- Tocilizumab-Mesalamine Rectal Enema
- Tocilizumab-Mesalamine Rectal Suspension